Class information for:
Level 1: CLOPIDOGREL//PRASUGREL//TICAGRELOR

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
310 3676 39.3 89%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
131 3       HEMATOLOGY//HAEMOPHILIA//TRANSFUSION 66936
966 2             CLOPIDOGREL//PRASUGREL//TICAGRELOR 10690
310 1                   CLOPIDOGREL//PRASUGREL//TICAGRELOR 3676

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 CLOPIDOGREL authKW 6060080 36% 55% 1329
2 PRASUGREL authKW 2905529 11% 84% 417
3 TICAGRELOR authKW 2436259 10% 82% 356
4 PLATELET REACTIVITY authKW 738842 4% 57% 155
5 THIENOPYRIDINES authKW 592383 4% 48% 148
6 CLOPIDOGREL RESISTANCE authKW 558386 2% 82% 82
7 ANTIPLATELET THERAPY authKW 506066 6% 28% 221
8 CANGRELOR authKW 470359 2% 80% 71
9 ACUTE CORONARY SYNDROME authKW 298732 12% 8% 450
10 HIGH ON TREATMENT PLATELET REACTIVITY authKW 280692 1% 87% 39

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Cardiac & Cardiovascular System 41438 42% 0% 1536
2 Peripheral Vascular Diseases 17483 21% 0% 758
3 Hematology 13029 19% 0% 685
4 Pharmacology & Pharmacy 3963 21% 0% 772
5 Medicine, General & Internal 770 8% 0% 305
6 Medicine, Research & Experimental 117 3% 0% 123
7 Medical Laboratory Technology 117 1% 0% 44
8 Chemistry, Medicinal 58 2% 0% 73
9 Neuroimaging 48 1% 0% 22
10 Respiratory System 33 1% 0% 52

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 SINAI THROMBOSIS 183651 1% 54% 41
2 MED JACKSONVILLE 174853 2% 28% 75
3 TIMI STUDY GRP 147644 3% 19% 93
4 HEARTDRUG S 135870 1% 55% 30
5 ST ANTONIUS PLATELET FUNCT 87715 0% 81% 13
6 CARDIOL 76212 33% 1% 1200
7 HOP UNIV NORD 71773 0% 79% 11
8 UPPSALA CLIN 59564 2% 11% 64
9 UMRS 608 56053 0% 75% 9
10 MED CARDIOL 5 49829 0% 100% 6

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PLATELETS 69039 3% 7% 119
2 THROMBOSIS AND HAEMOSTASIS 30217 5% 2% 191
3 JACC-CARDIOVASCULAR INTERVENTIONS 19796 1% 4% 54
4 JOURNAL OF THROMBOSIS AND THROMBOLYSIS 19438 2% 4% 66
5 CIRCULATION-CARDIOVASCULAR INTERVENTIONS 13438 1% 5% 34
6 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 13406 4% 1% 160
7 JOURNAL OF THROMBOSIS AND HAEMOSTASIS 11208 2% 2% 73
8 THROMBOSIS RESEARCH 11138 3% 1% 118
9 AMERICAN HEART JOURNAL 9488 4% 1% 129
10 AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS 8659 1% 5% 21

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 CLOPIDOGREL 6060080 36% 55% 1329 Search CLOPIDOGREL Search CLOPIDOGREL
2 PRASUGREL 2905529 11% 84% 417 Search PRASUGREL Search PRASUGREL
3 TICAGRELOR 2436259 10% 82% 356 Search TICAGRELOR Search TICAGRELOR
4 PLATELET REACTIVITY 738842 4% 57% 155 Search PLATELET+REACTIVITY Search PLATELET+REACTIVITY
5 THIENOPYRIDINES 592383 4% 48% 148 Search THIENOPYRIDINES Search THIENOPYRIDINES
6 CLOPIDOGREL RESISTANCE 558386 2% 82% 82 Search CLOPIDOGREL+RESISTANCE Search CLOPIDOGREL+RESISTANCE
7 ANTIPLATELET THERAPY 506066 6% 28% 221 Search ANTIPLATELET+THERAPY Search ANTIPLATELET+THERAPY
8 CANGRELOR 470359 2% 80% 71 Search CANGRELOR Search CANGRELOR
9 ACUTE CORONARY SYNDROME 298732 12% 8% 450 Search ACUTE+CORONARY+SYNDROME Search ACUTE+CORONARY+SYNDROME
10 HIGH ON TREATMENT PLATELET REACTIVITY 280692 1% 87% 39 Search HIGH+ON+TREATMENT+PLATELET+REACTIVITY Search HIGH+ON+TREATMENT+PLATELET+REACTIVITY

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 WINTER, MP , KOZINSKI, M , KUBICA, J , ARADI, D , SILLER-MATULA, JM , (2015) PERSONALIZED ANTIPLATELET THERAPY WITH P2Y12 RECEPTOR INHIBITORS: BENEFITS AND PITFALLS.POSTEPY W KARDIOLOGII INTERWENCYJNEJ. VOL. 11. ISSUE 4. P. 259 -280 160 83% 8
2 SILLER-MATULA, JM , TRENK, D , SCHROR, K , GAWAZ, M , KRISTENSEN, SD , STOREY, RF , HUBER, K , (2013) RESPONSE VARIABILITY TO P2Y(12) RECEPTOR INHIBITORS EXPECTATIONS AND REALITY.JACC-CARDIOVASCULAR INTERVENTIONS. VOL. 6. ISSUE 11. P. 1111-1128 142 90% 34
3 BONELLO, L , TANTRY, US , MARCUCCI, R , BLINDT, R , ANGIOLILLO, DJ , BECKER, R , BHATT, DL , CATTANEO, M , COLLET, JP , CUISSET, T , ET AL (2010) CONSENSUS AND FUTURE DIRECTIONS ON THE DEFINITION OF HIGH ON-TREATMENT PLATELET REACTIVITY TO ADENOSINE DIPHOSPHATE.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. VOL. 56. ISSUE 12. P. 919 -933 85 93% 438
4 SILLER-MATULA, JM , TRENK, D , SCHROR, K , GAWAZ, M , KRISTENSEN, SD , STOREY, RF , HUBER, K , (2015) HOW TO IMPROVE THE CONCEPT OF INDIVIDUALISED ANTIPLATELET THERAPY WITH P2Y(12) RECEPTOR INHIBITORS - IS AN ALGORITHM THE ANSWER?.THROMBOSIS AND HAEMOSTASIS. VOL. 113. ISSUE 1. P. 37 -52 129 88% 9
5 ROLLINI, F , FRANCHI, F , ANGIOLILLO, DJ , (2016) SWITCHING P2Y(12)-RECEPTOR INHIBITORS IN PATIENTS WITH CORONARY ARTERY DISEASE.NATURE REVIEWS CARDIOLOGY. VOL. 13. ISSUE 1. P. 11 -27 72 95% 15
6 MALLOUK, N , LABRUYERE, C , RENY, JL , CHAPELLE, C , PIOT, M , FONTANA, P , GRIS, JC , DELAVENNE, X , MISMETTI, P , LAPORTE, S , (2012) PREVALENCE OF POOR BIOLOGICAL RESPONSE TO CLOPIDOGREL A SYSTEMATIC REVIEW.THROMBOSIS AND HAEMOSTASIS. VOL. 107. ISSUE 3. P. 494 -506 146 87% 20
7 JIANG, XL , SAMANT, S , LESKO, LJ , SCHMIDT, S , (2015) CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF CLOPIDOGREL.CLINICAL PHARMACOKINETICS. VOL. 54. ISSUE 2. P. 147 -166 134 71% 8
8 FRANCHI, F , ANGIOLILLO, DJ , (2015) NOVEL ANTIPLATELET AGENTS IN ACUTE CORONARY SYNDROME.NATURE REVIEWS CARDIOLOGY. VOL. 12. ISSUE 1. P. 30 -47 103 67% 37
9 GLOWKA, F , KARAZNIEWICZ-LADA, M , DANIELAK, D , (2012) GENETIC AND NON-GENETIC FACTORS AFFECTING THE RESPONSE TO CLOPIDOGREL THERAPY.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 13. ISSUE 5. P. 663 -683 110 89% 13
10 XIE, HG , ZOU, JJ , HU, ZY , ZHANG, JJ , YE, F , CHEN, SL , (2011) INDIVIDUAL VARIABILITY IN THE DISPOSITION OF AND RESPONSE TO CLOPIDOGREL: PHARMACOGENOMICS AND BEYOND.PHARMACOLOGY & THERAPEUTICS. VOL. 129. ISSUE 3. P. 267 -289 155 63% 23

Classes with closest relation at Level 1


Rank Class id link
1 36936 CASE MIX GROUP CLASSIFICATION//CHARISMA TRIAL//ECON WORKING GRP
2 5185 ASPIRIN RESISTANCE//ASPIRIN//PFA 100
3 10627 BIVALIRUDIN//PERCUTANEOUS CORONARY INTERVENTION//ENOXAPARIN
4 17743 TICLOPIDINE//TICLOPIDINE HYDROCHLORIDE//E5510
5 11108 NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME//ACUTE CORONARY SYNDROME//TERRENCE DONNELLY HEART
6 21109 TRIPLE ANTITHROMBOTIC THERAPY//ATRIAL INFARCTION//ANTITHROMBOTIC REGIMENS
7 17435 CILOSTAZOL//CLIN PHARMACOKINET PHARMACODYNAM METAB//TRIPLE ANTIPLATELET THERAPY
8 4532 EPTIFIBATIDE//ABCIXIMAB//TIROFIBAN
9 4132 GLYCOPROTEIN VI//GPVI//PLATELETS
10 37094 STICKY PLATELET SYNDROME//PLATELET HYPERAGGREGABILITY//PEAR1

Go to start page